Inspire Medical Systems, Inc. (NYSE:INSP) is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, INSP is expected to report 2Q20 loss of $ 1.1 per share from revenue of $ 7.85 million.
For the full year, analysts anticipate top line of $ 78.47 million, while looking forward to loss of $ 3.13 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 115.00 million ~ $ 119.00 million
Click Here For More Historical Outlooks Of Inspire Medical Systems, Inc.
Previous Quarter Performance
Inspire Medical Systems, Inc. recorded loss for the first quarter of $ 0.67 per share, from the revenue of $ 21.35 million. The quarterly revenues enlarged 31.38 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.57 per share from $ 21.26 million in revenue. The bottom line results missed street analysts by $ 0.1 or 17.54 percent, at the same time, top line results outshined analysts by $ 0.09 million or 0.42 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Inspire Medical Systems, Inc.
Stock Performance
According to the previous trading day, closing price of INSP was $ 101.41, representing a 150.21 % increase from the 52 week low of $ 40.53 and a 3.91 % decrease over the 52 week high of $ 105.54.
The company has a market capital of $ 2.71 billion and is part of the Healthcare sector and Medical Devices industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”INSP” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Analyst recommendations
- On 15th July 2020, initiated by Goldman Sachs Group at Buy rating, with $ 148.00 target price.
Conference Call
Inspire Medical Systems, Inc. will be hosting a conference call at 5:00 PM eastern time on 4th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.inspiresleep.com
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patients breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
